[go: up one dir, main page]

MX2015006011A - Pastilla medicinal a base de ibuprofeno sodico dihidratado. - Google Patents

Pastilla medicinal a base de ibuprofeno sodico dihidratado.

Info

Publication number
MX2015006011A
MX2015006011A MX2015006011A MX2015006011A MX2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A
Authority
MX
Mexico
Prior art keywords
sodium dihydrate
ibuprofen sodium
medicinal
lozenge based
medicinal lozenge
Prior art date
Application number
MX2015006011A
Other languages
English (en)
Inventor
Jean-Francois Cordoliani
Nadine Harambillet
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48050846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015006011(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MX2015006011A publication Critical patent/MX2015006011A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

El tema de la presente invención son las pastillas medicinales para chupar, que tienen una consistencia sólida de tal manera que se disuelven en la cavidad oral, que comprenden al menos ibuprofeno sódico dihidratado como ingrediente activo, las cuales se destinan al tratamiento de condiciones orofaríngeas.
MX2015006011A 2012-11-14 2013-11-14 Pastilla medicinal a base de ibuprofeno sodico dihidratado. MX2015006011A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260815A FR2997856B1 (fr) 2012-11-14 2012-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
PCT/EP2013/073868 WO2014076203A1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Publications (1)

Publication Number Publication Date
MX2015006011A true MX2015006011A (es) 2015-09-10

Family

ID=48050846

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006011A MX2015006011A (es) 2012-11-14 2013-11-14 Pastilla medicinal a base de ibuprofeno sodico dihidratado.

Country Status (17)

Country Link
US (1) US20160287514A1 (es)
EP (1) EP2919752A1 (es)
JP (1) JP6258342B2 (es)
KR (1) KR20150084919A (es)
CN (1) CN104780907A (es)
AP (1) AP2015008515A0 (es)
AU (1) AU2013346775B2 (es)
BR (1) BR112015010808A2 (es)
CA (1) CA2890832A1 (es)
CL (1) CL2015001308A1 (es)
FR (1) FR2997856B1 (es)
MA (1) MA38162B1 (es)
MX (1) MX2015006011A (es)
RU (1) RU2015122217A (es)
TN (1) TN2015000176A1 (es)
WO (1) WO2014076203A1 (es)
ZA (1) ZA201504280B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物
WO2019104050A1 (en) * 2017-11-27 2019-05-31 Lodaat Pharmaceuticals Methods for preparing curcuminoid compositions
BR112022003190A2 (pt) * 2019-08-22 2022-05-17 Applied Biological Laboratories Inc Composições e métodos usando drogas anti-inflamatórias não esteroides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA34430C2 (uk) * 1991-05-13 2001-03-15 Дзе Бутс Компані Плс S(-)-2-(4-ізобутилфеніл)пропіонат натрію дигідрат, придатний для лікування запалення, болю і гіпертермії, фармацевтична композиція на його основі та спосіб одержання s(-)-2-(4-ізобутилфеніл)пропіонату натрію
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
PL381799A1 (pl) * 2004-06-07 2007-07-09 Strides Arcolab Limited Kompozycja farmaceutyczna zawierająca trwały i klarowny roztwór leku przeciwzapalnego w miękkiej kapsułce żelatynowej i sposób jej wytwarzania
CA2576642A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising a nsaid and a sugar alcohol made by melt extrusion
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
AU2007267612A1 (en) * 2006-05-26 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted carboxylic acid compounds
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法

Also Published As

Publication number Publication date
CN104780907A (zh) 2015-07-15
TN2015000176A1 (fr) 2016-10-03
JP2015537019A (ja) 2015-12-24
FR2997856A1 (fr) 2014-05-16
AP2015008515A0 (en) 2015-06-30
ZA201504280B (en) 2017-09-27
JP6258342B2 (ja) 2018-01-10
FR2997856B1 (fr) 2015-04-24
KR20150084919A (ko) 2015-07-22
EP2919752A1 (fr) 2015-09-23
CA2890832A1 (fr) 2014-05-22
AU2013346775B2 (en) 2018-06-28
BR112015010808A2 (pt) 2017-07-11
RU2015122217A (ru) 2017-01-10
AU2013346775A1 (en) 2015-07-02
MA38162A1 (fr) 2016-12-30
US20160287514A1 (en) 2016-10-06
MA38162B1 (fr) 2019-12-31
WO2014076203A1 (fr) 2014-05-22
CL2015001308A1 (es) 2015-08-28

Similar Documents

Publication Publication Date Title
EP3283065A4 (en) Methods for formulating orally ingestible compositions comprising lipophilic active agents
CR20150326A (es) Inhibidores de autotaxina
ME03323B (me) Paraziticidne oralne veterinarske kompozicije koje sadrže sistemski djelujuća aktivna sredstva, metodi i primjene istih
AR084057A1 (es) Composiciones para el cuidado de telas
CR20140508A (es) Moduladores de la ruta del complemento y usos de los mismos
CL2014002077A1 (es) Composicion farmaceutica que comprende fumarato de dimetilo; metodo de preparacion; capsula que comprende microtabletas de fumarato de dimetilo; metodo para el tratamiento, profilaxis o mejora de la esclerosis multiple.
CL2015000893A1 (es) Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.
IT1400982B1 (it) Collirio osmotico trans-epiteliale per la cura del cheratocono.
ECSP12011585A (es) Compuestos y composiciones para eltratamiento de enfermedades parasitarias
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
CR20120316A (es) Procesos para la fabricación de un agente farmacéuticamente activo
IN2015DN03984A (es)
HRP20181607T1 (hr) Stabilne oralne otopine za kombinirane aktivne farmaceutske sastojke
CU23970B1 (es) Forma galénica divisible que permite una liberación modificada del principio activo
PT3003285T (pt) Forma de administração farmacêutica sólida para libertação de pelo menos dois princípios ativos farmacêuticos na cavidade oral
BR112012028788A2 (pt) fabricação de grânulos sem ativos
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
CO6300935A2 (es) Formulaciones orales e inyectables de compuestos de tetraciclina
PE20150721A1 (es) Composicion farmaceutica que comprende gemigliptina y metformina, y metodo para su preparacion
BR112013019924A8 (pt) Composições para cuidado oral
BR112012030654A2 (pt) formas de dosagem oral de bendamustina
MX2015006011A (es) Pastilla medicinal a base de ibuprofeno sodico dihidratado.
CO7121334A2 (es) Formulaciones vesiculares
CL2013001684A1 (es) Composicion farmaceutica de administracion oral que comprende alisporivir, un componente lipofilico, un tensoactivo y un componente hidrofilico.